392
Views
0
CrossRef citations to date
0
Altmetric
Pharmacoeconomic Trends

The importance of model inputs and assumptions in conducting health technology assessments of novel drugs

&
Pages 1107-1109 | Received 19 May 2017, Accepted 11 Jul 2017, Published online: 04 Aug 2017
 

Transparency

Declaration of funding

This study was funded by Amgen, Inc.

Declaration of financial/other relationships

TP and JPM are employees of Precision Health Economics, which was funded by Amgen, Inc. for this study. JME peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Acknowledgments

The authors would like to thank the three anonymous reviewers for their thoughtful feedback and input on the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.